✦ LIBER ✦

DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment

✍ Scribed by Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns…

Book ID: 120707392
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 308 KB
Volume: 7
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar1787

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of the major histocompatibil

Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients

✍ Alfonso Martinez; Marina Salido; Gema Bonilla; Dora Pascual-Salcedo; Miguel Fern 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

## Objective: To determine whether major histocompatibility complex (mhc) polymorphisms are associated with a good or poor response to infliximab therapy in patients with rheumatoid arthritis (ra). ## Methods: Seventy-eight infliximab-treated patients with ra were genotyped for hla-drb1, hla-dqa1

Discontinuation of infliximab and potent

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

✍ van den Broek, M.; Klarenbeek, N. B.; Dirven, L.; van Schaardenburg, D.; Hulsman 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 216 KB

Impact of trough serum level on radiogra

Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study

✍ Tsutomu Takeuchi; Nobuyuki Miyasaka; Kazuhiko Inoue; Tohru Abe; Takao Koike 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 307 KB

RAPID3 (Routine Assessment of Patient In

RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol

✍ Theodore Pincus; Victoria Furer; Edward Keystone; Yusuf Yazici; Martin J. Bergma 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 150 KB 👁 2 views

Evidence of radiographic benefit of trea

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

✍ J. S. Smolen; C. Han; M. Bala; R. N. Maini; J. R. Kalden; D. van der Heijde; F. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views